JEWISH GENERAL HOSPITAL
🇺🇸United States
Clinical Trials
94
Active:20
Completed:39
Trial Phases
5 Phases
Phase 1:8
Phase 2:9
Phase 3:3
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (58 trials with phase data)• Click on a phase to view related trials
Not Applicable
31 (53.4%)Phase 2
9 (15.5%)Phase 1
8 (13.8%)Phase 4
7 (12.1%)Phase 3
3 (5.2%)The Impact of Fasting Duration on Quality of Recovery After Cesarean Section
Not yet recruiting
- Conditions
- Quality ImprovementQuality of Recovery From AnaesthesiaCesarean SectionFasting ( 6H for Solid ; 2H for Clear Fluid )
- First Posted Date
- 2024-11-22
- Last Posted Date
- 2024-11-29
- Lead Sponsor
- Jewish General Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT06701929
Assessment of Recovery of Functional Capillary Surface Area in Patients Undergoing a Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension
Not Applicable
Recruiting
- Conditions
- Pulmonary ThromboembolismsHypertension, Pulmonary
- First Posted Date
- 2023-02-09
- Last Posted Date
- 2023-02-09
- Lead Sponsor
- Jewish General Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT05719415
- Locations
- 🇨🇦
David Langleben, Montreal, Quebec, Canada
Safety and Efficacy Evaluation of Transperineal Irreversible Electroporation (IRE) of Anterior Prostate Cancer
Not Applicable
Not yet recruiting
- Conditions
- Prostate Cancer
- First Posted Date
- 2022-08-23
- Last Posted Date
- 2022-08-23
- Lead Sponsor
- Jewish General Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT05512663
Long-acting Parasternal Blocks for Analgesia After Cardiac Surgery
Phase 3
Completed
- Conditions
- Coronary Artery Bypass Graft Surgery
- Interventions
- Drug: Standard of careDrug: Parasternal blocks
- First Posted Date
- 2022-01-13
- Last Posted Date
- 2024-06-10
- Lead Sponsor
- Jewish General Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT05191745
- Locations
- 🇨🇦
Jewish General Hospital, Montreal, Quebec, Canada
Preoperative Maltodextrin's Effect on Cardiac Function in Cardiac Surgery
Phase 4
Not yet recruiting
- Conditions
- Left Ventricular DysfunctionQuality of RecoveryRight Ventricular Dysfunction
- Interventions
- Drug: Placebo solution
- First Posted Date
- 2022-01-12
- Last Posted Date
- 2025-02-24
- Lead Sponsor
- Jewish General Hospital
- Target Recruit Count
- 70
- Registration Number
- NCT05188222
- Locations
- 🇨🇦
Jewish General Hospital, Montreal, Quebec, Canada
- Prev
- 1
- 2
- 3
- 4
- 5
- 19
- Next
News
No news found